| An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models CE Canal, DE Felsing, Y Liu, W Zhu, JAT Wood, CK Perry, R Vemula, ... ACS chemical neuroscience 6 (7), 1259-1270, 2015 | 38 | 2015 |
| Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction DE Felsing, NC Anastasio, JM Miszkiel, SR Gilbertson, JA Allen, ... PLoS One 13 (8), e0203137, 2018 | 31 | 2018 |
| A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses CE Canal, D Morgan, D Felsing, K Kondabolu, NE Rowland, ... Journal of Pharmacology and Experimental Therapeutics 349 (2), 310-318, 2014 | 31 | 2014 |
| Advances in dopamine D1 receptor ligands for neurotherapeutics DE Felsing, MK Jain, JA Allen Current topics in medicinal chemistry 19 (16), 1365-1380, 2019 | 30 | 2019 |
| Synthesis and pharmacological evaluation of noncatechol G protein biased and unbiased dopamine D1 receptor agonists P Wang, DE Felsing, H Chen, SR Raval, JA Allen, J Zhou ACS Medicinal Chemistry Letters 10 (5), 792-799, 2019 | 21 | 2019 |
| Discovery of potent and brain-penetrant GPR52 agonist that suppresses psychostimulant behavior P Wang, DE Felsing, H Chen, SJ Stutz, RE Murphy, KA Cunningham, ... Journal of medicinal chemistry 63 (22), 13951-13972, 2020 | 17 | 2020 |
| Maternal opioid exposure culminates in perturbed murine neurodevelopment and hyperactive phenotype in adolescence CR Schlagal, TJ Dunn, P Xu, DE Felsing, CR Merritt, S Manja, RG Fox, ... Neuroscience 463, 272-287, 2021 | 16 | 2021 |
| Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT1A and 5-HT7 G protein-coupled receptor affinity, 3D-QSAR and molecular modeling CK Perry, AB Casey, DE Felsing, R Vemula, M Zaka, NB Herrington, ... Bioorganic & Medicinal Chemistry 28 (3), 115262, 2020 | 15 | 2020 |
| Small‐Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models CM Sampson, JM Kasper, DE Felsing, SR Raval, N Ye, P Wang, ... Pharmacology Research & Perspectives 6 (5), e00425, 2018 | 15 | 2018 |
| Ligand-directed serotonin 5-HT2C receptor desensitization and sensitization DE Felsing, CE Canal, RG Booth European journal of pharmacology 848, 131-139, 2019 | 10 | 2019 |
| Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice TS Saraf, DE Felsing, JL Armstrong, RG Booth, CE Canal Epilepsy research 175, 106677, 2021 | 9 | 2021 |
| Serotonin 5-HT2C Receptor Cys23Ser Single Nucleotide Polymorphism Associates with Receptor Function and Localization In Vitro MA Land, HL Chapman, BD Davis-Reyes, DE Felsing, JA Allen, ... Scientific reports 9 (1), 16737, 2019 | 9 | 2019 |
| Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists J Zhou, JA Allen, P Wang, DE Felsing US Patent 11,773,065, 2023 | 1 | 2023 |
| Dopamine Receptors: Neurotherapeutic Targets for Substance Use Disorders AN Nilson, DE Felsing, JA Allen GPCRs as Therapeutic Targets 2, 677-731, 2022 | 1 | 2022 |
| Homology Modeling Inspired Synthesis of 5-HT2A Receptor Inhibitors: A Diazepine Analogue of the Atypical Antipsychotic JL13 E Mongeau, G Yuan, Z Minden, S Waldron, R Booth, D Felsing, ... Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2017 | | 2017 |
| Drug Discovery Targeting Serotonin G Protein-Coupled Receptors in the Treatment of Neuropsychiatric Disorders DE Felsing University of Florida, 2016 | | 2016 |
John A AllenAssociate Professor, Department of Pharmacology, University of Texas Medical BranchVerified email at utmb.edu
